Abstract
Store-operated calcium entry (SOCE) is the most common mode of calcium influx in non-excitable cells, including immune cells. The two STIM isoforms mediate SOCE as well as Fc receptor (FcR)—downstream activation of macrophages and mast cells—which appears to be relevant in vivo, in models of antibody-dependent tissue injury and allergy. Hence, the pathway of SOCE may be a therapeutic target for treatment of immune complex (IC)-mediated autoimmunity and allergic asthma. The pyrazole derivative, BTP2 is an efficient inhibitor of SOCE, which has already been shown to attenuate allergic inflammation. However, its effect on Fc gamma receptor (FcγR) signaling and IC-induced tissue injury had not yet been studied. Here, we show that BTP2 is a potent inhibitor of SOCE in primary macrophages, blocking FcγR-mediated responses. To investigate the effect of inhibition of SOCE in IC-mediated tissue injury, we induced reverse passive Arthus reaction to IgG immune complexes in the skin and lungs of BTP2- or control-treated mice. Treatment with BTP2 resulted in markedly attenuated inflammation in both the skin and the lungs. Our findings indicate the involvement of SOCE in FcγR-mediated responses in vitro and in vivo and suggest that BTP2-mediated inhibition of SOCE may have a therapeutic potential on IC-mediated autoimmunity.
Similar content being viewed by others
References
Gessner, J.E., H. Heiken, A. Tamm, and R.E. Schmidt. 1998. The IgG Fc receptor family. Annals of Hematology 6: 231–248.
Baumann, U., J. Köhl, T. Tschernig, K. Schwerter-Strumpf, J.S. Verbeek, R.E. Schmidt, and J.E. Gessner. 2000. A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. Journal of Immunology 164: 1065–1070.
Baumann, U., N. Chouchakova, B. Gewecke, J. Köhl, M.C. Carroll, R.E. Schmidt, and J.E. Gessner. 2001. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. Journal of Immunology 167: 1022–1037.
Shaw, P.J., and S. Feske. 2012. Physiological and pathophysiological functions of SOCE in the immune system. Frontiers in Bioscience 4: 2253–2268.
Shaw, P.J., and S. Feske. 2012. Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity. The Journal of Physiology 590: 4157–4167.
Oh-Hora, M., M. Yamashita, P.G. Hogan, S. Sharma, E. Lamperti, W. Chung, M. Prakriya, et al. 2008. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nature Immunology 9: 432–443.
Matsumoto, M., Y. Fujii, A. Baba, M. Hikida, T. Kurosaki, and Y. Baba. 2011. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34: 703–714.
Braun, A., J.E. Gessner, D. Varga-Szabo, S.N. Syed, S. Konrad, D. Stegner, T. Vögtle, et al. 2009. STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation. Blood 113: 1097–1104.
.Baba, Y., K. Nishida, Y. Fujii, T. Hirano, M. Hikida, and T. Kurosaki. 2008. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nature Immunology 9: 81–88.
Sogkas, G., T. Vögtle, E. Rau, B. Gewecke, D. Stegner, R.E. Schmidt, B. Nieswandt, and J.E. Gessner. 2015. Orai1 controls C5a-induced neutrophil recruitment in inflammation. European Journal of Immunology 45: 2143–2153.
Gwack, Y., S. Srikanth, M. Oh-Hora, P.G. Hogan, E.D. Lamperti, M. Yamashita, C. Gelinas, et al. 2008. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Molecular and Cellular Biology 28: 5209–5222.
Vig, M., W.I. DeHaven, G.S. Bird, J.M. Billingsley, H. Wang, P.E. Rao, A.B. Hutchings, et al. 2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nature Immunology 9: 89–96.
Ohga, K., R. Takezawa, Y. Arakida, Y. Shimizu, and J. Ishikawa. 2008. Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo. International Immunopharmacology 8: 1787–1792.
Law, M., J.L. Morales, L.F. Mottram, A. Iyer, B.R. Peterson, and A. August. 2011. Structural requirements for the inhibition of calcium mobilization and mast cell activation by the pyrazole derivative BTP2. International Journal of Biochemistry and Cell Biology 43: 1228–1239.
Sogkas, G., D. Stegner, S.N. Syed, T. Vögtle, E. Rau, B. Gewecke, R.E. Schmidt, B. Nieswandt, and J.E. Gessner. 2015. Cooperative and alternate functions for STIM1 and STIM2 in macrophage activation and in the context of inflammation. Immunity, Inflammation and Disease 3: 154–170.
Ishikawa, J., K. Ohga, T. Yoshino, R. Takezawa, A. Ichikawa, H. Kubota, and T. Yamada. 2003. A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes. Journal of Immunology 170: 4441–4449.
Chen, Y., M.L. Smith, G.X. Chiou, S. Ballaron, M.P. Sheets, E. Gubbins, U. Warrior, et al. 2002. TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators. Cellular Immunology 220: 134–142.
Yoshino, T., J. Ishikawa, K. Ohga, T. Morokata, R. Takezawa, H. Morio, Y. Okada, et al. 2007. YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. European Journal of Pharmacology 560: 225–233.
Djillani, A., O. Nüße, and O. Dellis. 2014. Characterization of novel store-operated calcium entry effectors. Biochimica et Biophysica Acta 1843: 2341–2347.
Shushakova, N., J. Skokowa, J. Schulman, U. Baumann, J. Zwirner, R.E. Schmidt, and J.E. Gessner. 2002. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. The Journal of Clinical Investigation 110: 1823–1830.
Syed, S.N., S. Konrad, K. Wiege, B. Nieswandt, F. Nimmerjahn, R.E. Schmidt, and J.E. Gessner. 2009. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. European Journal of Immunology 39: 3343–3356.
Steinckwich, N., J.P. Frippiat, M.J. Stasia, M. Erard, R. Boxio, C. Tankosic, I. Doignon, and O. Nusse. 2007. Potent inhibition of store-operated Ca2+ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2. Journal of Leukocyte Biology 81: 1054–1064.
Malbec, O., L. Cassard, M. Albanesi, F. Jönsson, D. Mancardi, G. Chicanne, B. Payrastre, et al. 2016. Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. Science Signaling 9: ra126.
Ma, H.T., and M.A. Beaven. 2011. Regulators of Ca(2+) signaling in mast cells: potential targets for treatment of mast cell-related diseases? Advances in Experimental Medicine and Biology 716: 62–90.
Acknowledgments
This work was supported by Deutsche Forschungsgemeinschaft (DFG) SFB 587, GE 892/ 11-1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Rights and permissions
About this article
Cite this article
Sogkas, G., Rau, E., Atschekzei, F. et al. The Pyrazole Derivative BTP2 Attenuates IgG Immune Complex-induced Inflammation. Inflammation 41, 42–49 (2018). https://doi.org/10.1007/s10753-017-0661-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-017-0661-y